ACE2 and COVID-19: The pathogenesis of COVID-19, including gastrointestinal symptoms, remains elusive, despite tissue-specific immunofluorescence detection of SARS-CoV-2 binding to a specific receptor such as angiotensin-converting enzyme 2 (ACE2), predominantly expressed in the gastrointestinal tract (5, 6).